Attachment 4 - Price Template.xlsx
XLSX spreadsheet 14 KB Posted
- Solicitation number
- 75N95023Q00329
About this file
This document is a price template attachment for a federal contract solicitation from the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse. The solicitation seeks proposals for Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant services. The price template provides cells for contractors to list their fully burdened hourly labor rates, estimated hours, and other direct costs including travel for the base period of September 15, 2023 through September 14, 2024 as well as two option periods. Contractors may propose multiple subject matter experts and are asked to provide a separate narrative if proposing additional personnel or costs beyond those included in the template. Pricing assumptions not covered in the template should also be documented in a separate narrative.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment 1_SOW.docx | DOCX document | |
| CSS_75N95023Q00329.pdf | ||
| Attachment 6 - Electronic Invoicing Instructions.pdf | ||
| CSS_75N95023Q00329.pdf | ||
| Attachment 3 - Representations and Certifications.docx | DOCX document | |
| Attachment 4 - Price Template.xlsx | XLSX spreadsheet | |
| Attachment 1_SOW.pdf | ||
| Attachment 2 - Additional Terms and Conditions_FAR 52.212-5 (May 2022).pdf | ||
| Attachment 5_Tech Eval Criteria.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRICE TEMPLATE
| ATTACHMENT #4 - PRICE TEMPLATE | *MUST COMPLETE THESE CELLS |
| RFQ NUMBER: 75N95023Q00329 | |
| Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant | *ONLY COMPLETE IF NECESSARY |
IMPORTANT: THE GOVERNMENT ANTICIPATES 1-3 SMEs WILL BE REQUIRED
Contractor's Name:
| BASE PERIOD | ||
| 9/15/2023 - 9/14/2024 | OPTION PERIOD ONE | |
| 9/15/2024 - 9/14/2025 | OPTION PERIOD TWO |
9/15/2025 - 9/14/2026
| Bioassay Development SME(s) | |||
| Fully Burdened Labor Rate - $ per hr | |||
| Fully Burdened Labor - Est. (20 Hrs) | $ - 0 | $ - 0 | $ - 0 |
| Fully Burdened Labor - Optional (up to 780 Hrs) | $ - 0 | $ - 0 | $ - 0 |
| Fully Burdened Labor - Total (800 Hrs) | $ - 0 | $ - 0 | $ - 0 |
| ODCs - Travel | $ 1,200.00 | $ 1,200.00 | $ 1,200.00 |
| ODCs - Total |
| Fully Burdened Labor Total + ODC Total | $ - 0 | $ - 0 | $ - 0 |
| Per-SME Amount | $ - 0 |
Number of Proposed SMEs
| TOTAL AMOUNT | $ - 0 | |
| NOTES: | ||
| 1. Respondents must certify compliance with HHS Salary Rate Limitation in Attachment 3 - Representations |
and Certifications."
| 2. Fully burdened labor rates include wages, fringe benefits, overhead, G&A expenses, and profit. |
| 3. Other Direct Costs (ODCs) are costs not previously |
identified as a direct material cost, direct labor cost, or indirect cost.
| 4. Respondents may add rows for additional proposed personnel and/or ODCs as necessary. |
| 5. Respondents must include separate price narrative for any additional proposed personnel or ODCs besides travel. |
| This narrative must explain why they believe the additional personnel and/or ODCs are necessary to fulfill this requirement. |
| 6. Respondents must document any price-related assumptions that are not covered by this template in a separate price narrative. |
File details come from the government source that posted it. Updated .